FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells

Nucleic Acids Research

Volumn 37, Issue 12, 2009, Pages 3996-4009

  Han, Weidong ^a   Wu, Zhiqiang ^a   Zhao, Yali ^a   Meng, Yuanguang ^a   Si, Yiling ^a   Yang, Jie ^a   Fu, Xiaobing ^a   Yu, Li ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX PROTEIN E47; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; FOUR AND A HALF LIM ONLY PROTEIN 2; HETERODIMER; INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 2; INHIBITOR OF DIFFERENTIATION 3; INHIBITOR OF DIFFERENTIATION 4; INHIBITOR OF DIFFERENTIATION PROTEIN; LIM PROTEIN; RETINOIC ACID; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CONTROLLED STUDY; DELETION MUTANT; E BOX ELEMENT; ENZYME INHIBITION; GENE TARGETING; GENETIC CONSERVATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TRANSCRIPTION INITIATION; UPREGULATION;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; DNA; E-BOX ELEMENTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELIX-LOOP-HELIX MOTIFS; HOMEODOMAIN PROTEINS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; MUSCLE PROTEINS; NEUROBLASTOMA; REPRESSOR PROTEINS; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS; TWO-HYBRID SYSTEM TECHNIQUES; UP-REGULATION;

EID: 67651146626     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp332     Document Type: Article

References (50)

1. Massari,M.E. and Murre,C. (2000) Helix-loop-helix proteins: Regulators of transcription in eucaryotic organisms. Mol. Cell Biol., 20 429-440.
2. Norton,J.D., Deed,R.W., Craggs,G. and Sablitzky,F. (1998) Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol., 8, 58-65.
3. Atchley,W.R. and Fitch,W.M. (1997) A natural classification of the basic helix-loop-helix class of transcription factors. Proc. Natl Acad. Sci. USA., 94, 5172-5176.
4. Langlands,K., Yin,X., Anand,G. and Pronchowink,E.V. (1997) Differential interactions of Id proteins with basic helix-loop-helix transcription factors. J. Biol. Chem., 272, 19785-19793.
5. Perk,J., Iavarone,A. and Benezra,R. (2005) Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer, 5, 603-614.
6. Ruzinova,M.B. and Benezra,R. (2003) Id proteins in development, cell cycle and cancer. Trends Cell Biol., 13, 410-418.
7. Yokota,Y. (2002) Id and development. Oncogene, 20, 8290-8298.
8. Iavarone,A. and Lasorella,A. (2006) ID proteins as targets in cancer and tools in neurology. Trends Mol. Med., 12, 588-594.
9. Fukuma,M., Okita,H., Hata,J. and Umezawa,A. (2003) Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ ets protein in Ewing sarcoma. Oncogene, 22, 1-9.
10. Lasorella,A., Noseda,M., Beyna,M., Yokota,Y. and Iavarone,A. (2000) Id2 is a retinoblastoma protein target and mediates signaling by Myc oncoproteins. Nature, 407, 592-598.
11. Lasorella,A., Boldrini,R., Dominici,C., Donfrancesco,A., Yokota,Y., Inserra,A. and Iavarone,A. (2002) Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma. Cancer Res., 62, 301-306.
12. Nishimori,H., Sasaki,Y., Yoshida,K., Irifune,H., Zembutsu,H., Tanaka,T., Aoyama,T., Hosaka,T., Kawaguchi,S., Wada,T. et al. (2002) The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene, 21, 8302-8309.
13. Lasorella,A., Rothschild,G., Yokota,Y., Russell,R.G. and Iavarone,A. (2005) Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice. Mol. Cell Biol., 25, 3563-3574.
14. Iavarone,A., Garg,P., Lasorella,A., Hsu,J. and Israel,M.A. (1994) The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev., 8, 1270-1284.
15. Lasorella,A., Uo,T. and Iavarone,A. (2001) Id proteins at the cross-road of development and cancer. Oncogene, 20, 8326-8333.
16. Lasorella,A. and Iavarone,A. (2006) The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system. Proc. Natl Acad. Sci. USA, 103, 4976-4981.
17. Li,X., Luo,Y., Starremans,P.G., McNamara,C.A., Pei,Y. and Zhou,J. (2005) Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nature Cell Biol., 7, 1202-1212.
18. Liu,C.J., Ding,B., Wang,H. and Lengyel,P. (2002) The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins. Mol. Cell Biol., 22, 2893-2905.
19. Johannessena,M., Møllera,S., Hansena,T., Moensa,U. and van Ghelueb,M. (2006) The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol. Life Sci., 63, 268-284.
20. Tanahashi,H. and Tabira,T. (2000) Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein. Hum. Mol. Genet., 9, 2281-2289.
21. Kleiber,K., Strebhardt,K. and Martin,B.T. (2007) The biological relevance of FHL2 in tumor cells and its role as a putative cancer target. Anticancer Res., 27, 55-62.
22. Lasorella,A., Stegmüller,J., Guardavaccaro,D., Liu,G., Carro,M.S., Rothschild,G., de la Torre-Ubieta,L., Pagano,M., Bonni,A. and Iavarone,A. (2006) Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth. Nature, 442, 471-474.
23. Yan,J., Zhu,J., Zhang,H., Lu,Q., Huang,C. and Ye,Q. (2003) BRCA1 interacts with FHL2 and enhances FHL2 transcription function. FEBS Lett., 553, 183-189.
24. Ding,L., Wang,Z., Yan,J., Yang,X., Liu,A., Qiu,W., Zhu,J., Han,J., Zhang,H., Lin,J. et al. (2009) Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. J. Clin. Invest., 119, 349-361.
25. Han,W.D., Zhao,Y.L., Meng,Y.G., Zang,L., Wu,Z.Q., Li,Q., Si,Y.L., Huang,K., Ba,J.M., Morinaga,H. et al. (2007) Estrogenically regulated ERa target gene LRP16 interacts with ERα and enhances the receptor's transcriptional activity. Endocr-Relat. Cancer, 14 741-753.
26. Yang,J., Zhao,Y.L., Wu,Z.Q., Si,Y.L., Meng,Y.G., Fu,X.B., Mu,Y.M. and Han,W.D. (2009) The single-macro domain protein LRP16 is an essential cofactor of androgen receptor. Endocr-Relat. Cancer, 16, 139-153.
27. KIP2 to regulate cell cycle in neural cells. Mol. Cell Biol., 26, 4351-4361.
28. Labalette,C., Renard,C.A., Neuveut,C., Buendia,M.A. and Wei,Y. (2004) Interaction and functional cooperation between the LIM Protein FHL2, CBP/ p300 and β-Catenin. Mol. Cell Biol., 24, 10689-10702.
29. Muller,J.M., Isele,U., Metzger,E., Rempel,A., Moser,M., Pscherer,A., Breyer,T., Holubarsch,C., Buettner,R. and Schüle,R. (2000) FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J. 19, 359-369.
30. Wibley,J., Deed,R., Jasiok,M., Douglas,K. and Norton,J. (1996) A homology model of the Id-3 helix-loop-helix domain as a basis for structure-function predictions. Biochem. Biophys. Acta., 1294 138-146.
31. Hill,A.A. and Riley,P. (2004) Di.erential regulation of Hand1 homodimer and Hand1-E12 heterodimer activity by the cofactor FHL2. Mol. Cell Biol., 24, 9835-9847.
32. Shen,C.P. and Kadesch,T. (1995) B-cell-specific DNA binding by an E47 homodimer. Mol. Cell Biol., 15, 4518-4524.
33. Toma,J.G., El-Bizri,H., Barnabe-Heider,F., Aloyz,R. and Miller,F.D. (2000) Evidence that helix-loop-helix proteins collaborate with retinoblastoma tumor suppressor protein to regulate cortical neurogenesis. J. Neurosci., 20, 7648-7656.
34. Wang,S., Sdrulla,A., Johnson,J.E., Yokota,Y. and Barres,B.A. (2001) A role for the helix-loop-helix protein Id2 in the control of oligodendrocyte development. Neuron, 29, 603-614.
35. Abemayor,E. and Sidell,N. (1989) Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. Environ. Health Perspect., 80, 3-15.
36. Sidell,N., Sara.an,T., Kelly,M., Tsuchida,T. and Haussler,M. (1986) Retinoic acid-induced differentiation of human neuroblastoma: A cell variant system showing two distinct responses. Exp. Cell Biol., 54, 287-300.
37. López-Carballo,G., Moreno,L., Masiá,S., Pérez,P. and Barettino,D. (2002) Activation of phosphatidylinositol 3-kinase/AKT signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J. Biol. Chem. 277, 25297-25304.
38. Bach,I. (2000) The LIM domain: Regulation by association. Mech. Dev. 91, 5-17.
39. Kadrmas,J.L. and Beckerle,M.C. (2004) The LIM domain: From the cytoskeleton to the nucleus. Nat. Rev. Mol. Cell Biol., 5, 920-931.
40. Lange,S., Auerbach,D., McLoughlin,P., Perriard,E., Schafer,B.W., Perriard,J.C. and Elher,E. (2002) Subcellular targeting of metabolic nzymes to titin in heart muscle may be mediated by DRAL/FHL-2. J. Cell Sci., 115, 4925-4936.
41. Bai,S., Kitaura,H., Zhao,H., Chen,J., Müller,J.M., Schüle,R., Darnay,B., Novack,D.V., Ross,F.P. and Teitelbaum,S.L. (2005) FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J. Clin. Invest., 115, 2742-2751.
42. Chen,D., Xu,W., Bales,E., Colmenares,C., Conacci-Sorrell,M., Ishii,S., Stavnezer,E., Campisi,J., Fisher,D.E., Ben-Ze'ev,A. et al. (2003) SKI activates Wnt/beta-catenin signaling in human melanoma. Cancer Res., 63, 6626-6634.
43. Labalette,C., Noüet,Y., Sobczak-Thepot,J., Armengol,C., Levillayer,F., Gendron,M.C., Renard,C.A., Regnault,B., Chen,J., Buendia,M.A. et al. (2008) The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation. J. Biol. Chem., 283, 15201-15208.
44. Martin,B.T., Kleiber,K., Wixler,V., Raab,M., Zimmer,B., Kaufmann,M. and Strebhardt,K. (2007) FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells. Cell Cycle, 6, 1779-1788.
45. Martin,B., Schneider,R., Janetzky,S., Waibler,Z., Pandur,P., Kühl,M., Behrens,J., von der Mark,K., Starzinski-Powitz,A. and Wixler,V. (2002) The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts. J. Cell Biol., 159, 113-122.
46. Hao,Y., Crenshaw,T., Moulton,T., Newcomb,E. and Tycko,B. (1993) Tumour-suppressor activity of H19 RNA. Nature, 365, 764-767.
47. Reik,W., Dean,W. and Walter,J. (2001) Epigenetic reprogramming in mammalian development. Science, 293, 1089-1093.
48. Chung,W.Y, Yuan,L., Feng,L., Hensle,T. and Tycko,B. (1996) Chromosome 11p15.5 regional imprinting: Comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. Hum. Mol. Genet., 5, 1101-1108.
49. Sherr,C. J. and Roberts,J. M. (1999) CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev., 13, 1501-1512.
50. Govoni,K.E., Amaar,Y.G., Kramer,A., Winter,E., Baylink,D.J. and Mohan,S. (2006) Regulation of insulin-like growth factor binding protein-5, four and a half lim-2, and a disintegrin and metalloprotease- 9 expression in osteoblasts. Growth Horm. IGF. Res., 16, 49-56.